Tassal is down some 10% today.

Yesterday, TGR presented at the Bell Potter agricultural forum. They provided a consistent trading update, i.e. nothing new or different from the Goldman’s emerging companies forum back in April, or the Feb result before that, that we noted.

External research is worth relatively little in our process, but still, in the effort to search around for news we do note that Goldman’s had released a fairly rosy note just earlier in the week, as did UBS, with both brokers updating earnings and price targets. At the other end, Barrenjoey initiated with a particularly negative outlook and a $3 price target.

Broker notes can shift narratives, and the bearish Morgan Stanley note on insurance companies, from last week, certainly seemed to drive sentiment towards the sector for a while; hence, at the margin, we do care what is being written or said.

TGR has observable product prices (salmon) that are elevated and didn’t trade weakly. The stock is a value stock, and to the extent that value as a style has outperformed quality or growth of late, we would be surprised if a down day on the market had such an impact on a stock that wasn’t expensive to begin with.

Earnings assumptions also do not appear unduly high (noting the high salmon prices) such that a failure to give an upgrade (or to be more explicit in guidance) in yesterday’s outlook statement should result in a thesis breach for someone, somewhere.

But, and this is perhaps the main point of the note, markets are generally efficient and outright mistakes are rare. An accidental “fat finger trade” is not an idea you want to rely on a-priori.

So, although we hold the stock in the core portfolio, we prefer to wait until we have more information, given the portfolio’s risk tolerance, before looking to add. However, we remain happy enough to hold until given reason to do otherwise.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.